Fidelity Group of Funds > Variable Insurance Products Fund IV
VIP Health Care Portfolio
$1.16B
Avg Monthly Net Assets
$1.15B
Total Assets
$15.36M
Total Liabilities
$1.14B
Net Assets
VIP Health Care Portfolio is an Underlying fund in Variable Insurance Products Fund IV
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has three share classes
and monthly net assets of $1.16B.
On August 27th, 2024 it reported 101 holdings, the largest
being BOSTON SCIENTIFIC CORP (9.9%), UNITEDHEALTH GROUP INC (9.5%) and ELI LILLY and CO (9.3%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| VIP Health Care Portfolio - Initial Class | C000021062 | ||
| VIP Health Care Portfolio - Investor Class | C000021063 | ||
| VIP Health Care Portfolio - Service Class 2 | C000211329 |
Holdings
From latest NPORT-P, filed August 27th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | Long | Equity-common | US | $7M | 364K | 0.62 |
| ACELYRIN INC | Long | Equity-common | US | $573K | 130K | 0.05 |
| ACUMEN PHARMACEUTICALS INC | Long | Equity-common | US | $436K | 180K | 0.04 |
| AGILON HEALTH INC | Long | Equity-common | US | $10M | 2M | 0.86 |
| ALEDADE INC SER B1 PC PP | Long | Equity-preferred | US | $988K | 25K | 0.09 |
| ALEDADE INC SER E1 PC PP | Long | Equity-preferred | US | $426K | 11K | 0.04 |
| ALIGNMENT HEALTHCARE INC | Long | Equity-common | US | $7M | 850K | 0.58 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $1M | 642K | 0.13 |
| ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $23M | 96K | 2.05 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $365K | 9K | 0.03 |
| ARCELLX INC | Long | Equity-common | US | $3M | 60K | 0.29 |
| ARCUS BIOSCIENCES INC | Long | Equity-common | US | $2M | 110K | 0.15 |
| ARGENX SE SPONSORED ADR | Long | Equity-common | NL | $18M | 43K | 1.61 |
| ASCENDIS PHARMA AS SPON ADR (ASCENDIS PHARMA A/S) | Long | Equity-common | DK | $15M | 110K | 1.32 |
| ASIMOV INC SER B PC PP | Long | Equity-preferred | US | $567K | 13K | 0.05 |
| ASTRAZENECA PLC | Long | Equity-common | GB | $17M | 112K | 1.53 |
| AVIDITY BIOSCIENCES (AVIDITY BIOSCIENCES INC) | Long | Equity-common | US | $6M | 150K | 0.54 |
| BLUEPRINT MEDICINES CORP | Long | Equity-common | US | $11M | 104K | 0.98 |
| BOSTON SCIENTIFIC CORP | Long | Equity-common | US | $113M | 1M | 9.94 |
| BRIGHTSPRING HEALTH SERVICES INC | Long | Equity-common | US | $5M | 450K | 0.45 |
| BRUKER CORP | Long | Equity-common | US | $9M | 142K | 0.80 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $2M | 146K | 0.21 |
| CARIS LIFE SCIENCES INC PP | Long | Equity-common | US | $659K | 254K | 0.06 |
| CARIS LIFE SCIENCES INC SER D PC PP | Long | Equity-preferred | US | $1M | 398K | 0.09 |
| CELLDEX THERAPEUTICS INC | Long | Equity-common | US | $3M | 85K | 0.28 |
| CENTENE CORP (CENTENE CORP DEL) | Long | Equity-common | US | $17M | 250K | 1.46 |
| CIGNA GROUP (THE) | Long | Equity-common | US | $35M | 105K | 3.05 |
| CLEERLY INC SER C PC PP | Long | Equity-preferred | US | $2M | 180K | 0.17 |
| CVS HEALTH CORP | Long | Equity-common | US | $19M | 325K | 1.69 |
| CYTOKINETICS INC | Long | Equity-common | US | $11M | 200K | 0.95 |
| DANAHER CORP | Long | Equity-common | US | $66M | 264K | 5.78 |
| DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | Long | Equity-preferred | CN | $212K | 45K | 0.02 |
| EDGEWISE THERAPEUTICS INC | Long | Equity-common | US | $2M | 85K | 0.13 |
| EDWARDS LIFESCIENCES CORP | Long | Equity-common | US | $15M | 165K | 1.34 |
| ELEMENT BIOSCIENCES INC SER C PC PP | Long | Equity-preferred | US | $775K | 72K | 0.07 |
| ELEVATEBIO LLC SER C PC PP (ELEVATEBIO, LLC) | Long | Equity-preferred | US | $95K | 31K | 0.01 |
| ELI LILLY and CO | Long | Equity-common | US | $106M | 117K | 9.30 |
| ENDEAVOR BIOMEDICINES INC SERIES C PC PP | Long | Equity-preferred | US | $1M | 208K | 0.12 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $2M | 75K | 0.15 |
| EVOLENT HEALTH INC A | Long | Equity-common | US | $4M | 200K | 0.34 |
| EXACT SCIENCES CORP | Long | Equity-common | US | $12M | 280K | 1.04 |
| Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $4M | 4M | 0.36 |
| Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $13M | 13M | 1.17 |
| GALVANIZE THERAPEUTICS CONV 6% 02/28/2027 P/P | Long | Debt | US | $511K | – | 0.04 |
| GALVANIZE THERAPEUTICS SER B PC PERP PP | Long | Equity-preferred | US | $430K | 505K | 0.04 |
| GLAUKOS CORP | Long | Equity-common | US | $17M | 142K | 1.48 |
| IMMUNOCORE HOLDINGS LTD ADR (IMMUNOCORE HOLDINGS PLC) | Long | Equity-common | GB | $2M | 66K | 0.20 |
| INSCRIPTA INC SER E PC PP | Long | Equity-preferred | US | $473K | 158K | 0.04 |
| INSIGHTEC LTD SER G PC PP | Long | Equity-preferred | IL | $2M | 2M | 0.14 |
| INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $10M | 73K | 0.85 |
| INSULET CORP | Long | Equity-common | US | $24M | 118K | 2.09 |
| INTELLIA THERAPEUTICS INC | Long | Equity-common | US | $2M | 90K | 0.18 |
| INTUITIVE SURGICAL INC | Long | Equity-common | US | $20M | 45K | 1.74 |
| IQVIA HOLDINGS INC | Long | Equity-common | US | $12M | 56K | 1.04 |
| JANUX THERAPEUTICS INC | Long | Equity-common | US | $4M | 103K | 0.38 |
| KARDIUM INC CONV 10% 12/31/2026 PP (KARDIUM INC/CA) | Long | Equity-preferred | CA | $2M | – | 0.16 |
| KEROS THERAPEUTICS (KEROS THERAPEUTICS INC) | Long | Equity-common | US | $5M | 100K | 0.40 |
| LEGEND BIOTECH CORP SPON ADR | Long | Equity-common | KY | $18M | 400K | 1.56 |
| LIFESTANCE HEALTH GROUP INC | Long | Equity-common | US | $7M | 1M | 0.59 |
| LONZA GROUP AG | Long | Equity-common | CH | $5M | 10K | 0.48 |
| MASIMO CORP | Long | Equity-common | US | $14M | 114K | 1.26 |
| MCKESSON CORP | Long | Equity-common | US | $7M | 12K | 0.62 |
| MEDICAL MICROINSTRUMENTS INC SER C PC PP | Long | Equity-preferred | US | $2M | 47K | 0.14 |
| MEDICAL MICROINSTRUMENTS INC WT 02/16/2031 PP | Long | Equity-common | US | $29K | 2K | 0.00 |
| MERCK and CO INC NEW | Long | Equity-common | US | $47M | 382K | 4.15 |
| MERUS B.V. (MERUS NV) | Long | Equity-common | NL | $8M | 140K | 0.73 |
| MOLINA HEALTHCARE INC | Long | Equity-common | US | $3M | 10K | 0.26 |
| MOONLAKE IMMUNOTHERAPEUTICS | Long | Equity-common | KY | $274K | 6K | 0.02 |
| MORPHIC HOLDING INC | Long | Equity-common | US | $3M | 80K | 0.24 |
| NUVALENT INC-A | Long | Equity-common | US | $8M | 100K | 0.67 |
| OMADA HEALTH INC SER E PC PP | Long | Equity-preferred | US | $1M | 281K | 0.09 |
| ORUKA THERAPEUTICS INC PIPE | Long | Equity-common | US | $1M | 220K | 0.11 |
| PENUMBRA INC | Long | Equity-common | US | $37M | 205K | 3.24 |
| PHARVARIS BV | Long | Equity-common | NL | $2M | 106K | 0.18 |
| PHREESIA INC | Long | Equity-common | US | $5M | 222K | 0.41 |
| POSEIDA THERAPEUTICS INC | Long | Equity-common | US | $1M | 349K | 0.09 |
| PRIVIA HEALTH GROUP INC | Long | Equity-common | US | $11M | 630K | 0.96 |
| PROCEPT BIOROBOTICS CORP | Long | Equity-common | US | $6M | 92K | 0.49 |
| QIAGEN NV | Long | Equity-common | NL | $4M | 100K | 0.36 |
| RAPPORT THERAPEUTICS INC | Long | Equity-common | US | $930K | 40K | 0.08 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $48M | 46K | 4.25 |
| REPLIGEN (REPLIGEN CORP) | Long | Equity-common | US | $3M | 20K | 0.22 |
| ROYALTY PHARMA PLC | Long | Equity-common | GB | $9M | 350K | 0.81 |
| SALUDA MEDICAL INC SER E PC PP | Long | Equity-preferred | US | $1M | 164K | 0.10 |
| SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $5M | 30K | 0.42 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $2M | 80K | 0.17 |
| STRUCTURE THERAPEUTICS INC ADR | Long | Equity-common | KY | $4M | 102K | 0.35 |
| STRYKER CORP | Long | Equity-common | US | $28M | 82K | 2.44 |
| SUMMIT THERAPEUTICS INC | Long | Equity-common | US | $2M | 200K | 0.14 |
| SURGERY PARTNERS INC | Long | Equity-common | US | $13M | 545K | 1.14 |
| THERMO FISHER SCIENTIFIC INC | Long | Equity-common | US | $16M | 29K | 1.39 |
| UCB SA | Long | Equity-common | BE | $12M | 84K | 1.10 |
| UNITEDHEALTH GROUP INC | Long | Equity-common | US | $108M | 212K | 9.46 |
| VAXCYTE INC | Long | Equity-common | US | $16M | 218K | 1.45 |
| VEEVA SYS INC CL A | Long | Equity-common | US | $14M | 74K | 1.19 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $498K | 9K | 0.04 |
| VIRIDIAN THERAPEUTICS INC | Long | Equity-common | US | $3M | 250K | 0.29 |
| WUGEN INC CONV 10% 06/14/2025 PP | Long | Debt | US | $359K | – | 0.03 |
| WUGEN INC SER B PC PP | Long | Equity-preferred | US | $221K | 58K | 0.02 |
| XENON PHARMACEUTICALS INC | Long | Equity-common | CA | $7M | 185K | 0.63 |
| ZEALAND PHARMA A/S | Long | Equity-common | DK | $295K | 2K | 0.03 |
Address
Variable Insurance Products Fund IV
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
OSCAR MUNOZ
ROBERT A LAWRENCE
THOMAS A KENNEDY
BETTINA DOULTON
VICKI L FULLER
VIJAY ADVANI
THOMAS P BOSTICK
PATRICIA L KAMPLING
DONALD F DONAHUE
MICHAEL E WILEY
SUSAN TOMASKY
DAVID M THOMAS
Transfer Agents
Fidelity Investments Institutional Operations Company LLC
Pricing Services
REFINITIV US HOLDINGS INC
INTERCONTINENTAL EXCHANGE INC
Custodians
BANK HAPOALIM BM
CITIBANK EUROPE PLC
CITIBANK N.A.
SSB GMBH GERMANY - CBF
INTESA SANPAOLO SPA
STANDARD CHARTERED BANK
BNP PARIBAS GREECE
SEB NORWAY
Standard Chartered Bank
HSBC BANK (CHINA) COMPANY LIMITED
SKANDINAVISKA ENSKILDA BANKEN
HSBC - JAPAN
UNICREDIT BANK HUNGARY ZRT
BNP PARIBAS BELGIUM
STANDARD CHARTERED BANK
HSBC AUSTRALIA
BANK HANDLOWY W WARSZAWIE SA
CITIBANK NA
BNP PARIBAS NETHERLANDS
THE HONGKONG + SHANGHAI BANKIN
STANDARD CHARTERED
STATE STREET TRUST COMPANY CANADA
STATE STREET BANK AND TRUST COMPANY
STATE STREET SERVICES (UK) LIMITED
CITIBANK MUMBAI
HSBC NEW ZEALAND
EUROCLEAR
BANCO NACIONAL DE MEXICO SA
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
FIRSTRAND BANK LIMITED
Citibank Europe Plc
BNP PARIBAS FRANCE
Shareholder Servicing Agents
Fidelity Investments Institutional Operations Company LLC
Admins
Fidelity Service Company
Brokers
UBS GROUP AG
MORGAN STANLEY
ROYAL BANK OF CANADA
CITIGROUP INC
GOLDMAN SACHS GROUP INC (THE)
BARCLAYS PLC
VIRTU FINANCIAL INC
BANK OF AMERICA CORPORATION
JPMORGAN CHASE and CO
BANK OF MONTREAL QUE